Kouanfack C - Search Results

1

HIV-1 drug-resistance mutations among newly diagnosed patients before scaling-up programmes in Burkina Faso and Cameroon.

Vergne L, Diagbouga S, Kouanfack C, Aghokeng A, Butel C, Laurent C, Noumssi N, Tardy M, Sawadogo A, Drabo J, Hien H, Zekeng L, Delaporte E, Peeters M. Vergne L, et al. Among authors: kouanfack c. Antivir Ther. 2006;11(5):575-9. Antivir Ther. 2006. PMID: 16964825

2

A detailed characterization of drug resistance during darunavir/ritonavir monotherapy highlights a high barrier to the emergence of resistance mutations in protease but identifies alternative pathways of resistance.

Abdullahi A, Diaz AG, Fopoussi OM, Beloukas A, Fokom Defo V, Kouanfack C, Torimiro J, Geretti AM. Abdullahi A, et al. Among authors: kouanfack c. J Antimicrob Chemother. 2024 Feb 1;79(2):339-348. doi: 10.1093/jac/dkad386. J Antimicrob Chemother. 2024. PMID: 38153241 Free PMC article. Clinical Trial.

3

Relation between interleukin-6 concentrations and oxidative status of HIV infected patients with /or at risk of Kaposi disease in Yaounde.

Voufo RA, Kouotou AE, Tatah NJ, TeTo G, Gueguim C, Ngondé CME, Njiguet Tepa AG, Gabin A, Amazia F, Yembeau NL, Kouanfack C, Anatole PC. Voufo RA, et al. Among authors: kouanfack c. Virol J. 2023 Jul 25;20(1):165. doi: 10.1186/s12985-023-02109-9. Virol J. 2023. PMID: 37491285 Free PMC article.

4

Patient-reported outcomes with direct-acting antiviral treatment for hepatitis C in West and Central Africa (TAC ANRS 12311 trial).

Marcellin F, Mourad A, Lemoine M, Kouanfack C, Seydi M, Carrieri P, Attia A, Protopopescu C, Lacombe K, Boyer S. Marcellin F, et al. Among authors: kouanfack c. JHEP Rep. 2022 Dec 28;5(3):100665. doi: 10.1016/j.jhepr.2022.100665. eCollection 2023 Mar. JHEP Rep. 2022. PMID: 36686592 Free PMC article.

5

Effectiveness and safety of a generic fixed-dose combination of nevirapine, stavudine, and lamivudine in HIV-1-infected adults in Cameroon: open-label multicentre trial.

Laurent C, Kouanfack C, Koulla-Shiro S, Nkoué N, Bourgeois A, Calmy A, Lactuock B, Nzeusseu V, Mougnutou R, Peytavin G, Liégeois F, Nerrienet E, Tardy M, Peeters M, Andrieux-Meyer I, Zekeng L, Kazatchkine M, Mpoudi-Ngolé E, Delaporte E. Laurent C, et al. Among authors: kouanfack c. Lancet. 2004 Jul 3-9;364(9428):29-34. doi: 10.1016/S0140-6736(04)16586-0. Lancet. 2004. PMID: 15234853 Clinical Trial.

6

Antiretroviral drug resistance and routine therapy, Cameroon.

Laurent C, Kouanfack C, Vergne L, Tardy M, Zekeng L, Noumsi N, Butel C, Bourgeois A, Mpoudi-Ngolé E, Koulla-Shiro S, Peeters M, Delaporte E. Laurent C, et al. Among authors: kouanfack c. Emerg Infect Dis. 2006 Jun;12(6):1001-4. doi: 10.3201/eid1206.050860. Emerg Infect Dis. 2006. PMID: 16707062 Free PMC article.

7

Long-term safety, effectiveness and quality of a generic fixed-dose combination of nevirapine, stavudine and lamivudine.

Laurent C, Kouanfack C, Koulla-Shiro S, Njoume M, Nkene YM, Ciaffi L, Brulet C, Peytavin G, Vergne L, Calmy A, Mpoudi-Ngolé E, Delaporte E. Laurent C, et al. Among authors: kouanfack c. AIDS. 2007 Mar 30;21(6):768-71. doi: 10.1097/QAD.0b013e328045c4d7. AIDS. 2007. PMID: 17413701 Clinical Trial.

8

Tolerability and effectiveness of first-line regimens combining nevirapine and lamivudine plus zidovudine or stavudine in Cameroon.

Laurent C, Bourgeois A, Mpoudi-Ngolé E, Ciaffi L, Kouanfack C, Mougnutou R, Nkoué N, Calmy A, Koulla-Shiro S, Delaporte E. Laurent C, et al. Among authors: kouanfack c. AIDS Res Hum Retroviruses. 2008 Mar;24(3):393-9. doi: 10.1089/aid.2007.0219. AIDS Res Hum Retroviruses. 2008. PMID: 18327976 Clinical Trial.

9

Safety of stavudine in the treatment of HIV infection with a special focus on resource-limited settings.

Makinson A, Moing VL, Kouanfack C, Laurent C, Delaporte E. Makinson A, et al. Among authors: kouanfack c. Expert Opin Drug Saf. 2008 May;7(3):283-93. doi: 10.1517/14740338.7.3.283. Expert Opin Drug Saf. 2008. PMID: 18462186 Review.

10

Adherence to antiretroviral therapy assessed by drug level monitoring and self-report in cameroon.

Kouanfack C, Laurent C, Peytavin G, Ciaffi L, Ngolle M, Nkene YM, Essomba C, Calmy A, Mpoudi-Ngolé E, Delaporte E, Koulla-Shiro S; French National Agency for Research on AIDS 1274 Study Group. Kouanfack C, et al. J Acquir Immune Defic Syndr. 2008 Jun 1;48(2):216-9. doi: 10.1097/QAI.0b013e3181743955. J Acquir Immune Defic Syndr. 2008. PMID: 18520681 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

131 results

Search Page

Filters